<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32876811</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>643</EndPage><MedlinePgn>625-643</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02214-x</ELocationID><Abstract><AbstractText>A repeat expansion in C9orf72 is responsible for the characteristic neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) in a still unresolved manner. Proposed mechanisms involve gain-of-functions, comprising RNA and protein toxicity, and loss-of-function of the C9orf72 gene. Their exact contribution is still inconclusive and reports regarding loss-of-function are rather inconsistent. Here, we review the function of the C9orf72 protein and its relevance in disease. We explore the potential link between reduced C9orf72 levels and disease phenotypes in postmortem, in vitro, and in vivo models. Moreover, the significance of loss-of-function in other non-coding repeat expansion diseases is used to clarify its contribution in C9orf72 ALS/FTD. In conclusion, with evidence pointing to a multiple-hit model, loss-of-function on itself seems to be insufficient to cause neurodegeneration in C9orf72 ALS/FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Braems</LastName><ForeName>Elke</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6158-9208</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Experimental Neurology, Center for Brain and Disease Research, VIB, Campus Gasthuisberg, O&amp;N4, Herestraat 49, PB 602, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swinnen</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Experimental Neurology, Center for Brain and Disease Research, VIB, Campus Gasthuisberg, O&amp;N4, Herestraat 49, PB 602, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, 3000, Leuven, Belgium. ludo.vandenbosch@kuleuven.vib.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Experimental Neurology, Center for Brain and Disease Research, VIB, Campus Gasthuisberg, O&amp;N4, Herestraat 49, PB 602, 3000, Leuven, Belgium. ludo.vandenbosch@kuleuven.vib.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">In vitro</Keyword><Keyword MajorTopicYN="N">In vivo</Keyword><Keyword MajorTopicYN="N">Loss-of-function</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Postmortem</Keyword><Keyword MajorTopicYN="N">Repeat expansion</Keyword></KeywordList><CoiStatement>The authors declare to have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32876811</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02214-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abo-Rady M, Kalmbach N, Pal A, Schludi C, Janosch A, Richter T, et al. Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 2020;14:390&#x2013;405. doi: 10.1016/j.stemcr.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.01.010</ArticleId><ArticleId IdType="pmc">PMC7066330</ArticleId><ArticleId IdType="pubmed">32084385</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mahdawi S, Ging H, Bayot A, Cavalcanti F, La Cognata V, Cavallaro S, et al. Large interruptions of GAA repeat expansion mutations in Friedreich ataxia are very rare. Front Cell Neurosci. 2018;12:443. doi: 10.3389/fncel.2018.00443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00443</ArticleId><ArticleId IdType="pmc">PMC6258883</ArticleId><ArticleId IdType="pubmed">30519163</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Gascon E, Tran HH, Chou HJ, Gendron TF, Degroot S, et al. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol. 2013;126:385&#x2013;399. doi: 10.1007/s00401-013-1149-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1149-y</ArticleId><ArticleId IdType="pmc">PMC3753484</ArticleId><ArticleId IdType="pubmed">23836290</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Ferguson SM. C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease. Traffic. 2017;4:267&#x2013;276. doi: 10.1016/S2214-109X(16)30265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)30265-0</ArticleId><ArticleId IdType="pmc">PMC5389918</ArticleId><ArticleId IdType="pubmed">28266105</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J, Roczniak-Ferguson A, Ferguson SM. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol Biol Cell. 2016;27:3040&#x2013;3051. doi: 10.1091/mbc.E16-01-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-01-0003</ArticleId><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGLL, et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep. 2016;6:23204. doi: 10.1038/srep23204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23204</ArticleId><ArticleId IdType="pmc">PMC4793236</ArticleId><ArticleId IdType="pubmed">26979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Gendron TF, Murray ME, Dickson DW, Petrucelli L. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 2014;1584:15&#x2013;21. doi: 10.1016/j.brainres.2014.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.02.015</ArticleId><ArticleId IdType="pmc">PMC4130919</ArticleId><ArticleId IdType="pubmed">24530272</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Gendron TF, Baker MC, DeJesus-Hernandez M, Finch NCA, Brown PH, et al. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. 2015;130:863&#x2013;876. doi: 10.1007/s00401-015-1480-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1480-6</ArticleId><ArticleId IdType="pmc">PMC4655160</ArticleId><ArticleId IdType="pubmed">26437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E, Gijselinck I, Sieben A, Jovi&#x10d;i&#x107; A, et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Pfister V, Gaucherot A, Ruffenach F, Negroni L, Sellier C, et al. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39:e100574. doi: 10.1016/j.ejmg.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2017.11.001</ArticleId><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M, Willemsen R, Hukema RK, Sellier C. Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function? Eur J Med Genet. 2018;61:674&#x2013;679. doi: 10.1016/j.ejmg.2017.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2017.11.001</ArticleId><ArticleId IdType="pubmed">29223504</ArticleId></ArticleIdList></Reference><Reference><Citation>Botta A, Caldarola S, Vallo L, Bonifazi E, Fruci D, Gullotta F, et al. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2) Biochim Biophys Acta Mol Basis Dis. 2006;1762:329&#x2013;334. doi: 10.1016/j.bbadis.2005.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2005.11.004</ArticleId><ArticleId IdType="pubmed">16376058</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry A, Suzuki N, Wang J-Y, Moccia R, Mordes DA, Stewart MH, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8:93. doi: 10.1126/scitranslmed.aaf6038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6038</ArticleId><ArticleId IdType="pmc">PMC5024536</ArticleId><ArticleId IdType="pubmed">27412785</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali CP, Patino M, Tai YK, Ho WY, McLean CA, Morris CM, et al. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy. Acta Neuropathol. 2019;138:795&#x2013;811. doi: 10.1007/s00401-019-02045-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02045-5</ArticleId><ArticleId IdType="pmc">PMC6802287</ArticleId><ArticleId IdType="pubmed">31327044</ArticleId></ArticleIdList></Reference><Reference><Citation>Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, et al. Friedreich&#x2019;s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423&#x2013;1427. doi: 10.1126/science.271.5254.1423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.271.5254.1423</ArticleId><ArticleId IdType="pubmed">8596916</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandran V, Gao K, Swarup V, Versano R, Dong H, Jordan MC, et al. Inducible and reversible phenotypes in a novel mouse model of Friedreich&#x2019;s ataxia. Elife. 2017;6:e30054. doi: 10.7554/eLife.30054.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30054</ArticleId><ArticleId IdType="pmc">PMC5736353</ArticleId><ArticleId IdType="pubmed">29257745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Wang Y, Abe Y, Cheney L, Udd B, Li YP. Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J Mol Biol. 2007;368:8&#x2013;17. doi: 10.1016/j.jmb.2007.01.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.01.088</ArticleId><ArticleId IdType="pubmed">17335846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitiprolu M, Jagow C, Tremblay V, Bondy-Chorney E, Paris G, Savard A, et al. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat Commun. 2018;9:2794. doi: 10.1038/s41467-018-05273-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05273-7</ArticleId><ArticleId IdType="pmc">PMC6052026</ArticleId><ArticleId IdType="pubmed">30022074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Ann Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Higginbottom A, Connor-Robson N, Bayatti N, Bury JJ, Kirby J, et al. C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology. 2013;81:1719&#x2013;1721. doi: 10.1212/01.wnl.0000435295.41974.2e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000435295.41974.2e</ArticleId><ArticleId IdType="pmc">PMC3812108</ArticleId><ArticleId IdType="pubmed">24107864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Higginbottom A, Stopford MJ, Highley JR, Ince PG, Wharton SB, et al. Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. Acta Neuropathol. 2015;130:63&#x2013;75. doi: 10.1007/s00401-015-1429-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrionero A, Horvitz HR. A C9orf72 ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr Biol. 2018;28:1522&#x2013;1535.e5. doi: 10.1016/j.cub.2018.03.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2018.03.063</ArticleId><ArticleId IdType="pubmed">29731301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham F, Achuthan P, Akanni W, Allen J, Amode MR, Armean IM, et al. Ensembl 2019. Nucleic Acids Res. 2019;47:D745&#x2013;D751. doi: 10.1093/nar/gky1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1113</ArticleId><ArticleId IdType="pmc">PMC6323964</ArticleId><ArticleId IdType="pubmed">30407521</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Scaber J, Ababneh N, Lalic T, Weir G, Christian H, et al. C9orf72 hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal dementia. Stem Cells. 2016;34:2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang P, Pham JT, Heusler AR, Mistry NA, Vidensky S, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2014;80:415&#x2013;428. doi: 10.1016/j.neuron.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas AGL. Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction. Non-Coding RNA Res. 2018;3:178&#x2013;187. doi: 10.1016/j.ncrna.2018.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6260478</ArticleId><ArticleId IdType="pubmed">30533567</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D, Haass C. An amyloid-like cascade hypothesis for C9orf72 ALS/FTD. Curr Opin Neurobiol. 2016;36:99&#x2013;106. doi: 10.1016/j.conb.2015.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2015.10.009</ArticleId><ArticleId IdType="pubmed">26555807</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R, Belle KC, van Blitterswijk M, Belzil VV, Rademakers R, Dickson DW, et al. C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Exp Neurol. 2016;277:171&#x2013;177. doi: 10.1016/j.expneurol.2015.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.12.022</ArticleId><ArticleId IdType="pmc">PMC4761318</ArticleId><ArticleId IdType="pubmed">26746986</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RAK, Levina V, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Fomin V, Richard P, Hoque M, Li C, Gu Z, Fissore-O&#x2019;Leary M, et al. The C9ORF72 gene, implicated in amyotrophic lateral sclerosis and frontotemporal dementia, encodes a protein that functions in control of endothelin and glutamate signaling. Mol Cell Biol. 2018;38:e00155-18. doi: 10.1128/MCB.00155-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00155-18</ArticleId><ArticleId IdType="pmc">PMC6206455</ArticleId><ArticleId IdType="pubmed">30150298</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Poulter M, Lashley T, Rohrer JD, Polke JM, Beck J, et al. Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia. Acta Neuropathol. 2013;126:401&#x2013;409. doi: 10.1007/s00401-013-1147-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1147-0</ArticleId><ArticleId IdType="pmc">PMC3753468</ArticleId><ArticleId IdType="pubmed">23818065</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee K-H, et al. GGGGCC repeat expansion in C9ORF72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick P, Sellier C, Mackenzie IRA, Cheng CY, Tahraoui-Bories J, Martinat C, et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun. 2018;6:72. doi: 10.1186/s40478-018-0579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0579-0</ArticleId><ArticleId IdType="pmc">PMC6091050</ArticleId><ArticleId IdType="pubmed">30075745</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujikake N, Shin M, Shimizu S. Association between autophagy and neurodegenerative diseases. Front Neurosci. 2018;12:255. doi: 10.3389/fnins.2018.00255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00255</ArticleId><ArticleId IdType="pmc">PMC5972210</ArticleId><ArticleId IdType="pubmed">29872373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S, De Decker M, Mehta A, Swijsen A et al (2019) C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. bioRxiv 835082. 10.1101/835082</Citation></Reference><Reference><Citation>Gagliardi S, Pandini C, Garofalo M, Bordoni M, Pansarasa O, Cereda C. Long non coding RNAs and ALS: Still much to do. Non-Coding RNA Res. 2018;3:226&#x2013;231. doi: 10.1016/j.ncrna.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6260474</ArticleId><ArticleId IdType="pubmed">30533570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Petrucelli L. Disease mechanisms of C9ORF72 repeat expansions. Cold Spring Harb Perspect Med. 2018;8:a024224. doi: 10.1101/cshperspect.a024224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024224</ArticleId><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I, Van Mossevelde S, Van Der Zee J, Sieben A, Engelborghs S, De Bleecker J, et al. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter. Mol Psychiatry. 2016;21:1112&#x2013;1124. doi: 10.1038/mp.2015.159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.159</ArticleId><ArticleId IdType="pmc">PMC4960451</ArticleId><ArticleId IdType="pubmed">26481318</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg MVC, Bourc&#x2019;his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20:590&#x2013;607. doi: 10.1038/s41580-019-0159-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0159-6</ArticleId><ArticleId IdType="pubmed">31399642</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, Simko EAJ, Shaw G, Kim M, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.C9orf72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124.C9orf72</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885&#x2013;889. doi: 10.1038/nature04724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04724</ArticleId><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MB, Cady J, Zaidman C, Cooper P, Bali T, Allred P, et al. Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis. Neurobiol Aging. 2017;34:2234.e13&#x2013;2234.e19. doi: 10.1016/j.neurobiolaging.2013.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.03.006</ArticleId><ArticleId IdType="pmc">PMC3679344</ArticleId><ArticleId IdType="pubmed">23597494</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison RE, Bucci C, Vieira OV, Schroer TA, Grinstein S. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol Cell Biol. 2003;23:6494&#x2013;6506. doi: 10.1128/mcb.23.18.6494-6506.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.23.18.6494-6506.2003</ArticleId><ArticleId IdType="pmc">PMC193691</ArticleId><ArticleId IdType="pubmed">12944476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornburg D, Drepper C, Butter F, Meissner F, Sendtner M, Mann M. Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics. 2014;13:3410&#x2013;3420. doi: 10.1074/mcp.M113.037291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M113.037291</ArticleId><ArticleId IdType="pmc">PMC4256493</ArticleId><ArticleId IdType="pubmed">25193168</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002;99:7746&#x2013;7750. doi: 10.1073/pnas.122205699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.122205699</ArticleId><ArticleId IdType="pmc">PMC124340</ArticleId><ArticleId IdType="pubmed">12032354</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson JL, Finch NA, Baker MC, Kachergus JM, DeJesus-Hernandez M, Pereira K, et al. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers. Mol Neurodegener. 2020;15:7. doi: 10.1186/s13024-020-0359-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-0359-8</ArticleId><ArticleId IdType="pmc">PMC6993399</ArticleId><ArticleId IdType="pubmed">32000838</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase-modulated stress granules contain a diverse proteome and substructure. Cell. 2016;164:487&#x2013;498. doi: 10.1016/j.cell.2015.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.038</ArticleId><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, et al. Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet. 2000;9:901&#x2013;908. doi: 10.1093/hmg/9.6.901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.6.901</ArticleId><ArticleId IdType="pubmed">10767313</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones K, Jin B, Iakova P, Huichalaf C, Sarkar P, Schneider-Gold C, et al. RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol. 2011;179:2475&#x2013;2489. doi: 10.1016/j.ajpath.2011.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.07.013</ArticleId><ArticleId IdType="pmc">PMC3204036</ArticleId><ArticleId IdType="pubmed">21889481</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science. 2001;293:1068&#x2013;1070. doi: 10.1126/science.1063852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1063852</ArticleId><ArticleId IdType="pubmed">11498573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Waguri S, Chiba T, Murata S, Iwata JI, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880&#x2013;884. doi: 10.1038/nature04723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04723</ArticleId><ArticleId IdType="pubmed">16625205</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CAC, Vieira De S&#xe1; R, et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann Neurol. 2015;78:426&#x2013;438. doi: 10.1002/ana.24453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24453</ArticleId><ArticleId IdType="pmc">PMC4744979</ArticleId><ArticleId IdType="pubmed">26044557</ArticleId></ArticleIdList></Reference><Reference><Citation>Laflamme C, McKeever P, Kumar R, Schwartz J, Chen C, You Z et al (2018) Implementation of an antibody characterization process: application to the major ALS/FTD disease gene C9ORF72. bioRxiv 499350. 10.1101/499350</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6794092</ArticleId><ArticleId IdType="pubmed">31612854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A. 2013;110:4530&#x2013;4539. doi: 10.1073/pnas.1318835110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan Y, Sullivan PM, Hu F. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. Autophagy. 2019;15:871&#x2013;885. doi: 10.1080/15548627.2019.1569914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1569914</ArticleId><ArticleId IdType="pmc">PMC6526807</ArticleId><ArticleId IdType="pubmed">30696333</ArticleId></ArticleIdList></Reference><Reference><Citation>Langseth AJ, Kim J, Ugolino JE, Shah Y, Hwang HY, Wang J, et al. Cell-Type specific differences in promoter activity of the ALS-linked C9orf72 mouse ortholog. Sci Rep. 2017;7:5685. doi: 10.1038/s41598-017-05864-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-05864-2</ArticleId><ArticleId IdType="pmc">PMC5515847</ArticleId><ArticleId IdType="pubmed">28720882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K-HH, Zhang P, Kim HJ, Mitrea DM, Sarkar M, Freibaum BD, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Leskel&#xe4; H, Rostalski N, Remes T, Hiltunen H. C9orf72 proteins regulate autophagy and undergo autophagosomal or proteasomal degradation in a cell type-dependent manner. Cells. 2019;8:1233. doi: 10.3390/cells8101233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101233</ArticleId><ArticleId IdType="pmc">PMC6829620</ArticleId><ArticleId IdType="pubmed">31658762</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine TP, Daniels RD, Gatta AT, Wong LH, Hayes MJ. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29:499&#x2013;503. doi: 10.1093/bioinformatics/bts725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts725</ArticleId><ArticleId IdType="pmc">PMC3570213</ArticleId><ArticleId IdType="pubmed">23329412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, Russ J, Wu K, Neal D, Suh E, McNally AG, et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 2014;128:525&#x2013;541. doi: 10.1007/s00401-014-1286-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1286-y</ArticleId><ArticleId IdType="pmc">PMC4161616</ArticleId><ArticleId IdType="pubmed">24806409</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Liu Q, Lu CX, Cui B, Guo XN, Wang RR, et al. Identification of a novel loss-of-function C9orf72 splice site mutation in a patient with amyotrophic lateral sclerosis. Neurobiol Aging. 2016;47:219.e1&#x2013;219.e5. doi: 10.1016/j.neurobiolaging.2016.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.07.027</ArticleId><ArticleId IdType="pubmed">27595458</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Beyer A, Aebersold R. Leading edge review on the dependency of cellular protein levels on mRNA abundance. Cell. 2016;165:535&#x2013;550. doi: 10.1016/j.cell.2016.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.03.014</ArticleId><ArticleId IdType="pubmed">27104977</ArticleId></ArticleIdList></Reference><Reference><Citation>Longatti A, Lamb CA, Razi M, Yoshimura SI, Barr FA, Tooze SA. TBC1D14 regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes. J Cell Biol. 2012;197:659&#x2013;675. doi: 10.1083/jcb.201111079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201111079</ArticleId><ArticleId IdType="pmc">PMC3365497</ArticleId><ArticleId IdType="pubmed">22613832</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharjan N, K&#xfc;nzli C, Buthey K, Saxena S. C9ORF72 regulates stress granule formation and its deficiency impairs stress granule assembly, hypersensitizing cells to stress. Mol Neurobiol. 2017;54:3062&#x2013;3077. doi: 10.1007/s12035-016-9850-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9850-1</ArticleId><ArticleId IdType="pubmed">27037575</ArticleId></ArticleIdList></Reference><Reference><Citation>Marat AL, Dokainish H, McPherson PS. DENN domain proteins: regulators of Rab GTPases. J Biol Chem. 2011;286:13791&#x2013;13800. doi: 10.1074/jbc.R110.217067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R110.217067</ArticleId><ArticleId IdType="pmc">PMC3077579</ArticleId><ArticleId IdType="pubmed">21330364</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis RL, Holmes SE. Huntington&#x2019;s disease-like 2: a clinical, pathological, and molecular comparison to Huntington&#x2019;s disease. Clin Neurosci Res. 2003;3:187&#x2013;196. doi: 10.1016/S1566-2772(03)00061-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1566-2772(03)00061-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli A, Napierala M, Puccio H. Understanding the genetic and molecular pathogenesis of Friedreich&#x2019;s ataxia through animal and cellular models. Dis Model Mech. 2012;5:165&#x2013;176. doi: 10.1242/dmm.008706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.008706</ArticleId><ArticleId IdType="pmc">PMC3291638</ArticleId><ArticleId IdType="pubmed">22382366</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R, Liefhebber JM, Garc&#xed;a-Osta A, Miniarikova J, Cuadrado-Tejedor M, Espelosin M, et al. Targeting RNA-mediated toxicity in C9orf72 ALS and/or FTD by RNAi-based gene therapy. Mol Ther Nucleic Acids. 2019;16:26&#x2013;37. doi: 10.1016/j.omtn.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6393708</ArticleId><ArticleId IdType="pubmed">30825670</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine W, Sun L, Wen WK, Liu A, Jain R, Miguel MS, et al. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proc Natl Acad Sci USA. 2018;115:E11523&#x2013;E11531. doi: 10.1073/pnas.1814753115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814753115</ArticleId><ArticleId IdType="pmc">PMC6298088</ArticleId><ArticleId IdType="pubmed">30442666</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan CT, Russ J, Wood EM, Irwin DJ, Grossman M, McCluskey L, et al. C9orf72 promoter hypermethylation is neuroprotective. Neurology. 2015;84:1622&#x2013;1630. doi: 10.1212/WNL.0000000000001495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001495</ArticleId><ArticleId IdType="pmc">PMC4409587</ArticleId><ArticleId IdType="pubmed">25795648</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ZA, Sturm VE, Camsari GB, Karydas A, Yokoyama JS, Grinberg LT, et al. Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts. Neurol Neuroimmunol Neuroinflamm. 2016;3:e301. doi: 10.1212/NXI.0000000000000301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000301</ArticleId><ArticleId IdType="pmc">PMC5087253</ArticleId><ArticleId IdType="pubmed">27844039</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Gr&#xe4;sser FA, Gijselinck I, May S, Rentzsch K, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Nihei Y, Arzberger T, Zhou Q, Mackenzie IR, Hermann A, et al. Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition. EMBO Rep. 2016;17:1314&#x2013;1325. doi: 10.15252/embr.201541724.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541724</ArticleId><ArticleId IdType="pmc">PMC5007570</ArticleId><ArticleId IdType="pubmed">27461252</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Woehlbier U, Manque PA. The enigmatic role of C9ORF72 in autophagy. Front Neurosci. 2017;11:442. doi: 10.3389/fnins.2017.00442.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00442</ArticleId><ArticleId IdType="pmc">PMC5541066</ArticleId><ArticleId IdType="pubmed">28824365</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi M, Takeshima H, Hashimoto K, Kano M, Hashimoto K, Kano M, et al. Motor discoordination in mutant mice lacking junctophilin type 3. Biochem Biophys Res Commun. 2002;292:318&#x2013;324. doi: 10.1006/bbrc.2002.6649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2002.6649</ArticleId><ArticleId IdType="pubmed">11906164</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostra BA, Willemsen R. A fragile balance: FMR1 expression levels. Hum Mol Genet. 2003;12:R249&#x2013;R257. doi: 10.1093/hmg/ddg298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg298</ArticleId><ArticleId IdType="pubmed">12952862</ArticleId></ArticleIdList></Reference><Reference><Citation>Orourke JG, Bogdanik L, Yanez A, Lall D, Wolf AJ, Muhammad AKMG, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329. doi: 10.1126/science.aaf1064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf1064</ArticleId><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A, Kretner B, Abo-Rady M, Gla&#xdf; H, Naumann M, Japtok J et al (2020) High content live profiling reveals concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis. bioRxiv&#xa0;2020.04.15.040394.&#xa0;10.1101/2020.04.15.040394</Citation></Reference><Reference><Citation>Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, Caskey CT, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:817&#x2013;822. doi: 10.1016/0092-8674(91)90125-I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(91)90125-I</ArticleId><ArticleId IdType="pubmed">1878973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD. Motor neuron susceptibility in ALS/FTD. Front Neurosci. 2019;13:532. doi: 10.3389/fnins.2019.00532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00532</ArticleId><ArticleId IdType="pmc">PMC6610326</ArticleId><ArticleId IdType="pubmed">31316328</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheem O, Olufemi SE, Bachinski LL, Vihola A, Sirito M, Holmlund-Hampf J, et al. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. Am J Pathol. 2010;177:3025&#x2013;3036. doi: 10.2353/ajpath.2010.100179.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.100179</ArticleId><ArticleId IdType="pmc">PMC2993290</ArticleId><ArticleId IdType="pubmed">20971734</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Sim&#xf3;n-s&#xe1;nchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010.A</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, et al. C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathol Commun. 2016;4:37. doi: 10.1186/s40478-016-0306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0306-7</ArticleId><ArticleId IdType="pmc">PMC4832459</ArticleId><ArticleId IdType="pubmed">27079381</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J, Liu EY, Wu K, Neal D, Suh ER, Irwin DJ, et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 2015;129:39&#x2013;52. doi: 10.1007/s00401-014-1365-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1365-0</ArticleId><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S, Stauffer JE, Jiang J, Garcia SD, Taylor AE, Schulte D, et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 2017;135:459&#x2013;474. doi: 10.1007/s00401-017-1793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1793-8</ArticleId><ArticleId IdType="pmc">PMC5935138</ArticleId><ArticleId IdType="pubmed">29196813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakkas LI, Bogdanos DP, Kousvelari EE. Loss of C9orf72 function leads to autoimmunity. Ann Transl Med. 2017;5:60. doi: 10.21037/atm.2017.01.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2017.01.33</ArticleId><ArticleId IdType="pmc">PMC5326657</ArticleId><ArticleId IdType="pubmed">28251139</ArticleId></ArticleIdList></Reference><Reference><Citation>Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, et al. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol. 2009;175:748&#x2013;762. doi: 10.2353/ajpath.2009.090047.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.090047</ArticleId><ArticleId IdType="pmc">PMC2716970</ArticleId><ArticleId IdType="pubmed">19590039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmucker S, Puccio H. Understanding the molecular mechanisms of Friedreich&#x2019;s ataxia to develop therapeutic approaches. Hum Mol Genet. 2010;19:R103&#x2013;R110. doi: 10.1093/hmg/ddq165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq165</ArticleId><ArticleId IdType="pubmed">20413654</ArticleId></ArticleIdList></Reference><Reference><Citation>Seixas AI, Holmes SE, Takeshima H, Pavlovich A, Sachs N, Pruitt JL, et al. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis. Ann Neurol. 2012;71:245&#x2013;257. doi: 10.1002/ana.22598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22598</ArticleId><ArticleId IdType="pubmed">22367996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C, Campanari M, Julie Corbier C, Gaucherot A, Kolb-Cheynel I, Oulad-Abdelghani M, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297. doi: 10.15252/embj.201593350.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593350</ArticleId><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraj BT, Livesey MR, Zhao C, Gregory JM, James OT, Cleary EM, et al. C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity. Nat Commun. 2018;9:347. doi: 10.1038/s41467-017-02729-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02729-0</ArticleId><ArticleId IdType="pmc">PMC5783946</ArticleId><ArticleId IdType="pubmed">29367641</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q, Yang M, Liang C, Ma L, Zhang W, Jiang Z, et al. c9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy. 2019 doi: 10.1080/15548627.2019.1703353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1703353</ArticleId><ArticleId IdType="pubmed">31847700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivadasan R, Hornburg D, Drepper C, Frank N, Jablonka S, Hansel A, et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat Neurosci. 2016;19:1610&#x2013;1618. doi: 10.1038/nn.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4407</ArticleId><ArticleId IdType="pubmed">27723745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudria-Lopez E, Koppers M, de Wit M, van der Meer C, Westeneng HJ, Zundel CAC, et al. Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects. Acta Neuropathol. 2016;132:145&#x2013;147. doi: 10.1007/s00401-016-1581-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1581-x</ArticleId><ArticleId IdType="pmc">PMC4911370</ArticleId><ArticleId IdType="pubmed">27206760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM, Zhou X, Robins AM, Paushter DH, Kim D, Smolka MB, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016;4:51. doi: 10.1186/s40478-016-0324-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0324-5</ArticleId><ArticleId IdType="pmc">PMC4870812</ArticleId><ArticleId IdType="pubmed">27193190</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W, Van Den Bosch L. RNA toxicity in non-coding repeat expansion disorders. EMBO J. 2020;39:e101112. doi: 10.15252/embj.2018101112.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang BL. C9orf72&#x2019;s Interaction with Rab GTPases&#x2014;Modulation of Membrane Traffic and Autophagy. Front Cell Neurosci. 2016;10:228. doi: 10.3389/fncel.2016.00228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00228</ArticleId><ArticleId IdType="pmc">PMC5053994</ArticleId><ArticleId IdType="pubmed">27774051</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, et al. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS) Am J Med Genet Part B Neuropsychiatr Genet. 2007;144:566&#x2013;569. doi: 10.1002/ajmg.b.30482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30482</ArticleId><ArticleId IdType="pubmed">17427188</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet Semin Med Genet. 2000;97:195&#x2013;203. doi: 10.1002/1096-8628(200023)97:3&lt;195::AID-AJMG1037&gt;3.0.CO;2-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-8628(200023)97:3&lt;195::AID-AJMG1037&gt;3.0.CO;2-R</ArticleId><ArticleId IdType="pubmed">11449488</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrien M, Rouleau GA, Dion PA, Parker JA (2013) Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One 8:e83450. 10.1371/journal.pone.0083450</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861484</ArticleId><ArticleId IdType="pubmed">24349511</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, et al. Genetic screening in sporadic ALS and FTD. J Neurol Neurosurg Psychiatry. 2017;88:1042&#x2013;1044. doi: 10.1136/jnnp-2017-315995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315995</ArticleId><ArticleId IdType="pmc">PMC5740553</ArticleId><ArticleId IdType="pubmed">28642287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanneste J, Vercruysse T, Boeynaems S, Sicart A, Van Damme P, Daelemans D, et al. C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport. Sci Rep. 2019;9:15728. doi: 10.1038/s41598-019-52035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-52035-6</ArticleId><ArticleId IdType="pmc">PMC6823349</ArticleId><ArticleId IdType="pubmed">31673013</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite AJ, B&#xe4;umer D, East S, Neal J, Morris HR, Ansorge O, et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol Aging. 2014;35:1779.e5&#x2013;1779.e13. doi: 10.1016/j.neurobiolaging.2014.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.01.016</ArticleId><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 2016;35:1656&#x2013;1676. doi: 10.15252/embj.201694401.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201694401</ArticleId><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Grierson AJ, De Vos KJ. C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small GTPases. 2018;9:399&#x2013;408. doi: 10.1080/21541248.2016.1240495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1240495</ArticleId><ArticleId IdType="pmc">PMC5997165</ArticleId><ArticleId IdType="pubmed">27768524</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, Krishnamurthy K, Markandaiah SS, Shi Y, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13:805&#x2013;811. doi: 10.1038/nn.2575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2575</ArticleId><ArticleId IdType="pmc">PMC4038747</ArticleId><ArticleId IdType="pubmed">20581817</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, Zhang M, Bruni AC, Maletta RG, Colao R, Fratta P, et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 2015;129:715&#x2013;727. doi: 10.1007/s00401-015-1401-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1401-8</ArticleId><ArticleId IdType="pubmed">25716178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, MacNair L, McGoldrick P, McKeever P, McLean JR, Zhang M, et al. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann Neurol. 2015;78:568&#x2013;583. doi: 10.1002/ana.24469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24469</ArticleId><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, MacNair L, McLean J, McGoldrick P, McKeever P, Soleimani S, et al. C9orf72 isoforms in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Brain Res. 2016;1647:43&#x2013;49. doi: 10.1016/j.brainres.2016.04.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.062</ArticleId><ArticleId IdType="pubmed">27134035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Liang C, Swaminathan K, Herrlinger S, Lai F, Shiekhattar R, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016;2:e1601167. doi: 10.1126/sciadv.1601167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1601167</ArticleId><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh TH, Liu HF, Li YW, Lu CS, Shih HY, Chiu CC, et al. C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1. Exp Neurol. 2018;304:114&#x2013;124. doi: 10.1016/j.expneurol.2018.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.03.002</ArticleId><ArticleId IdType="pubmed">29522758</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Burberry A, Wang JY, Sandoe J, Ghosh S, Udeshi ND, Svinkina T, Mordes DA, Mok J, Charlton M, Li QZ, Carr SA, Eggan K. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32:929&#x2013;943. doi: 10.1101/gad.313932.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.313932.118</ArticleId><ArticleId IdType="pmc">PMC6075033</ArticleId><ArticleId IdType="pubmed">29950492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23:615&#x2013;624. doi: 10.1038/s41593-020-0619-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0619-5</ArticleId><ArticleId IdType="pmc">PMC7384305</ArticleId><ArticleId IdType="pubmed">32284607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoppino FCM, Militello RD, Slavin I, &#xc1;lvarez C, Colombo MI. Autophagosome formation depends on the small GTPase rab1 and functional ER exit sites. Traffic. 2010;11:1246&#x2013;1261. doi: 10.1111/j.1600-0854.2010.01086.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2010.01086.x</ArticleId><ArticleId IdType="pubmed">20545908</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>